BIA response to the R&D Roadmap

The BIA has responded to the Government's consultation on its R&D Roadmap.

In our response we:

• Support the Government's over-arching ambition that the increase in public investment in R&D should lead to increased business investment 
• Call on the Government to work collaboratively with the life sciences sector and develop a holistic approach to innovation policy that takes into account the role of the wider business environment in raising R&D investment and capturing the full economic, environmental and social benefits
• Support the expansion of Innovate UK's role in supporting innovation and champion the importance of sector-specific funding programmes like the Biomedical Catalyst
• Welcome the plans for a high-risk, high-reward research funding programme
• Recommend a bold and ambitious new Government-backed investment fund to support scaling life science businesses
• Recommend supporting innovation is embedded in NICE, NHS England and NHS Improvement policy
• Recommend funding for the MHRA to maintain the UK's position as a world-leading regulator